Waters Parkerson & Co’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.57M Sell
173,526
-60,762
-26% -$2.81M 0.36% 50
2026
Q2
$10M Sell
234,288
-60,889
-21% -$3.31M 0.49% 45
2026
Q1
$18.5M Buy
295,177
+30,693
+12% +$2.46M 0.95% 32
2025
Q4
$25.2M Buy
+264,484
New +$25.9M 1.24% 30

Other funds holding BSX

Waters Parkerson & Co's BSX Position: Q3 2026 in Review

Waters Parkerson & Co reduced its Boston Scientific (BSX) stake by 26% in Q3 2026, selling an estimated $2.81M and leaving 173,526 shares worth $7.57M. The position accounts for 0.36% of the portfolio, ranked #50.

Waters Parkerson & Co first reported a position in BSX in Q4 2025 and has held it in 4 quarters since. The position peaked at $25.2M in Q4 2025. 1,515 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Waters Parkerson & Co held 173,526 shares of Boston Scientific worth $7.57M as of Q3 2026.
  • Waters Parkerson & Co sold 60,762 Boston Scientific shares in Q3 2026, an estimated $2.81M.
  • Boston Scientific made up 0.36% of Waters Parkerson & Co's portfolio in Q3 2026, its #50 holding.
  • Waters Parkerson & Co first reported a position in Boston Scientific in Q4 2025 and has held it in 4 quarters since.
  • Waters Parkerson & Co's Boston Scientific position peaked at $25.2M in Q4 2025.
  • 1,515 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Waters Parkerson & Co's 13F filing for Q3 2026, filed 4 Nov 2026.